Skip to main content
Home

Main navigation

  • About HIPRA

      About HIPRA

    • Scopri HIPRA
    • Storia
    • Sostenibilità e CSR
    • HIPRA nel mondo
  • Salute Animale

      Salute Animale

    • I nostri prodotti
      • Vaccini
      • Kit di diagnosi
      • Prodotti farmacologici
    • I nostri servizi
      • A proposito di Smart Vaccination
      • HIPRASTATS
      • HIPRA Diagnos
      • HIPRA University
      • Strumenti online
    • Conoscenze
    • Notizie
    • Lösungen für
      • Suini
      • Avicoli
      • Bovini
      • Ovini e caprini
      • Conigli
      • Pesci
      • Canini
  • Salute delle persone

      Salute delle persone

    • I nostri prodotti
      • COVID-19
      • Salute digestiva (GoodGut)
    • Progetti R&S
    • Notizie
    • Stampa
  • Lavora con noi
  • Contattaci
Career
Search
Search

Notizie sulla salute umana

who we are
Notizie sulla salute umana

HIPRA launches a clinical trial to study its Covid-19 vaccine as 4th dose

09-11-2022
Umano
Esplora
covid vaccine

HIPRA creates a committee of experts for the Covid-19 vaccine project

13-07-2022
Umano
Azienda
Esplora
comité expertos

HIPRA starts a Phase III clinical trial of the Covid-19 vaccine with immunocompromised participants

13-06-2022
Umano
Esplora
Ensayo vacuna HIPRA

EMA starts rolling review of Covid-19 HIPRA’s vaccine

29-03-2022
Umano
Esplora
European Medicines Agency

GoodGut and Vall d'Hebron are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

27-03-2022
Umano
Esplora
goodgut news

AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19

25-03-2022
Umano
Esplora
Phase III
  • Load More
Home

Footer second

  • About HIPRA
  • Salute Animale
  • Salute delle persone

Footer third

  • Lavora con noi
  • Contattaci

Footer fourth

  • LinkedIn
  • YouTube

Footer

  • Termini d'uso
  • Informativa sulla privacy
  • Informativa sui cookie